
About Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma is a publicly listed company based in Osaka (Japan) founded in 1897. Pharmaceuticals, food ingredients, additives, and veterinary products are manufactured. Sumitomo Dainippon Pharma has completed 4 acquisitions, including Boston Biomedical, Sepracor and Sunovion. Its focus areas include Life Sciences, Immunotherapy, Small Molecule and Immunosuppressive Pathway Inhibitors.
Company details
Sumitomo Dainippon Pharma was founded in 1897 and is headquartered in Osaka, Japan. Operations focus on the pharmaceutical sector, where 11 products are developed for therapeutic areas including hypertension, Parkinsons disease, and antifungal treatments. Additional activities encompass the production of food ingredients, food additives, and veterinary products, supporting diverse markets in healthcare and nutrition.
- Headquarters Osaka, Japan
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website ds-pharma.com
- Social LinkedIn
- Investments & AcquisitionsBoston Biomedical
& 3 more
People of Sumitomo Dainippon Pharma
21 people are tracked at Sumitomo Dainippon Pharma (7 in leadership, 10 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Hitoshi Odagiri | Representative Director & Executive Vice President, Sales & Marketing Division | Leadership |
Hiroshi Nomura | Representative Director, President & CEO | Leadership |
Yoshiharu Ikeda | Director & Senior Executive Officer, Regulatory & Medical Affairs | Leadership |
Toru Kimura | Representative Director, Executive Vice President & Chief Scientific Officer | Leadership |
Jessica Lu | Marketing Director | Leadership |
Debra Phillips | Director, Clinical Development | Leadership |
Paul Meringolo | Director - Human Resources | Leadership |
Junsuke Fujii | Outside Audit & Supervisory Board Member | Board & advisors |
Minoru Usui | Outside Board Member | Board & advisors |
Nobuhiko Endo | Outside Board Member | Board & advisors |
Takashi Kutsunai | Audit & Supervisory Board Member | Board & advisors |
Masayo Tada | Chairman | Board & advisors |
Yutaka Atomi | Outside Board Member | Board & advisors |
Mayumi Mochizuki | Outside Audit & Supervisory Board Member | Board & advisors |
Yoshinori Oh-e | Audit & Supervisory Board Member | Board & advisors |
Saeko Arai | Outside Board Member | Board & advisors |
Yoshio Iteya | Outside Audit & Supervisory Board Member | Board & advisors |
Yudai Furuta | Research Scientist | Team |
Lisa Haase | Office Manager | Team |
Nishinaka Shigeyuki | Senior Executive Officer | Team |
1 more people are available in the full profile.
Complete people profiles for Sumitomo Dainippon Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Boston Biomedical, Sepracor and Sunovion.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical company that specializes in treatment of CNS and respiratory ailments | sunovion.com | Marlborough, United States | 1984 | Aug 2021 | β’β’β’β’ | |
Therapeutics for cancer and blood disorders are developed. | toleropharma.com | Lehi, United States | 2011 | Dec 2016 | $780M | |
Develops novel therapeutics for treatment of cancer | bostonbiomedical.com | Boston, United States | 2006 | Feb 2012 | $200M | |
Pharmaceutical products for respiratory and CNS disorders are developed. | sepracor.com | Marlborough, United States | 1984 | Sep 2009 | $2.6B |
Complete acquisition details for Sumitomo Dainippon Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sumitomo Dainippon Pharma
5 dated milestones of Sumitomo Dainippon Pharma across 124 years, from founding to its latest funding, stage changes and deals.
- Founded Sumitomo Dainippon Pharma is founded.
- Acquisition Acquires Sepracor.
- Acquisition Acquires Boston Biomedical.
- Acquisition Acquires Tolero Pharma.
- Acquisition Acquires Sunovion.
Web traffic of Sumitomo Dainippon Pharma
Websites that share an audience with Sumitomo Dainippon Pharma (ds-pharma.com).
Websites whose visitors overlap most with Sumitomo Dainippon Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abiogen.it | 100% | #1,682,569 | View details | ||
ir.horizon-pharma.com | ir.horizon-pharma.com | 99% | β | ||
| antarespharma.com | 98% | View details | |||
| bostonbiomedical.com | 97% | View details | |||
| daiichisankyo.com | 96% | 72.3K | #682,883 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for Sumitomo Dainippon Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sumitomo Dainippon Pharma
Complete news archive for Sumitomo Dainippon Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma was founded in 1897.
Sumitomo Dainippon Pharma is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Sumitomo Dainippon Pharma was founded in 1897 and is headquartered in Osaka, Japan. Operations focus on the pharmaceutical sector, where 11 products are developed for therapeutic areas including hypertension, Parkinsons disease, and antifungal treatments. Additional activities encompass the production of food ingredients, food additives, and veterinary products, supporting diverse markets in healthcare and nutrition.
Sumitomo Dainippon Pharma has made 4 acquisitions, including Boston Biomedical, Sepracor, and Sunovion.
